RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @ModernPathology: ⭐New #ModPathChat! In this episode, our guests, Drs. @SibaElHussein & @sanamloghavi discuss their experience on the…
RT @ModernPathology: ⭐New #ModPathChat! In this episode, our guests, Drs. @SibaElHussein & @sanamloghavi discuss their experience on the…
RT @ModernPathology: ⭐New #ModPathChat! In this episode, our guests, Drs. @SibaElHussein & @sanamloghavi discuss their experience on the…
RT @ModernPathology: ⭐New #ModPathChat! In this episode, our guests, Drs. @SibaElHussein & @sanamloghavi discuss their experience on the…
RT @ModernPathology: ⭐New #ModPathChat! In this episode, our guests, Drs. @SibaElHussein & @sanamloghavi discuss their experience on the…
So honored to be part of this amazing network! Thank you @SibaElHussein @sanamloghavi
RT @ModernPathology: ⭐New #ModPathChat! In this episode, our guests, Drs. @SibaElHussein & @sanamloghavi discuss their experience on the…
RT @ModernPathology: ⭐New #ModPathChat! In this episode, our guests, Drs. @SibaElHussein & @sanamloghavi discuss their experience on the…
RT @ModernPathology: ⭐New #ModPathChat! In this episode, our guests, Drs. @SibaElHussein & @sanamloghavi discuss their experience on the…
RT @ModernPathology: ⭐New #ModPathChat! In this episode, our guests, Drs. @SibaElHussein & @sanamloghavi discuss their experience on the…
RT @ModernPathology: ⭐New #ModPathChat! In this episode, our guests, Drs. @SibaElHussein & @sanamloghavi discuss their experience on the…
RT @ModernPathology: ⭐New #ModPathChat! In this episode, our guests, Drs. @SibaElHussein & @sanamloghavi discuss their experience on the…
⭐New #ModPathChat! In this episode, our guests, Drs. @SibaElHussein & @sanamloghavi discuss their experience on the role of social media in the dissemination of knowledge in #HemPath and establishing networks! 🎧Podcast: https://t.co/2ZURg9NOUG Paper:
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience | Modern Pathology https://t.co/CRtBv17IsY
Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience https://t.co/yHnJai26Xc
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience. https://t.co/5y28WSJzFA
Congrats on influential/relevant work you're doing when most needed ,disseminating #Hemepath educational information on #Pathweeter,is altruistic,contributes 2 bridge the gap on health disparities and accessibility,it sets the basis of goldstandards to b
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @anjuthevirgo: Blessings in disguise! @MDAndersonNews lectures is one of the few best thing happened in horrible pandemic 🙏 They gave…
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @sanamloghavi: Just out! proud of @SibaElHussein for 👇🏻& thankful to @ModernPathology for allowing us to share our #hemepathMDA story.…
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
Blessings in disguise! @MDAndersonNews lectures is one of the few best thing happened in horrible pandemic 🙏 They gave hempath a new platform You guys are the real heroes -@SibaElHussein @KirillLyapichev @sanamloghavi
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
Interesting experience from MDA on their use of social media in haematopathology
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @sanamloghavi: Just out! proud of @SibaElHussein for 👇🏻& thankful to @ModernPathology for allowing us to share our #hemepathMDA story.…
RT @sanamloghavi: Just out! proud of @SibaElHussein for 👇🏻& thankful to @ModernPathology for allowing us to share our #hemepathMDA story.…
Interesting publication by Dr. El Hussein @SibaElHussein on virtual platforms in #hemepath #pathology #path_edu
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @sanamloghavi: Just out! proud of @SibaElHussein for 👇🏻& thankful to @ModernPathology for allowing us to share our #hemepathMDA story.…
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
Just out! proud of @SibaElHussein for 👇🏻& thankful to @ModernPathology for allowing us to share our #hemepathMDA story. promoting #hemepath education & learning frm all of you in return is one of the most gratifying parts of our job! W/ sincere 🙏
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
That's an amazing work and a great way to take advantage of this social media. Congrats to you all !!!
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
RT @SibaElHussein: (1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in…
(1/5) Our article in @modernpathology is out, discussing how @hemepathMDA is rebranding the subspecialty of #hemepath in times of pressing need for virtual platforms for continuous medical learning➡️ https://t.co/kuUAeJs8nk @sanamloghavi @cmketcham @Leuke
Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience https://t.co/7SRoncqJYi